OPKO Health, Inc.

OPK Healthcare Diagnostics & Research

OPKO Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $606.9 million, down 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS grew 94.7%, free cash flow grew 46.5% and total debt rose 6.37%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.53 0.08 −4.97%
Market cap
$1.2B
P/E
0.0×
Fwd P/E
−4.7×
Dividend yield
—
F-score
4/9
Altman Z
−0.42
Beneish M
−2.81
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(13.32%) (17.14%) (16.92%) (5.88%)
Piotroski F-Score
3 4 3 2
ROA
(8.49%) (10.92%) (10.69%) (3.83%)
ROIC
(5.75%) (5.91%) (5.25%) (2.45%)
Return on Tangible Assets
(33.86%) (44.33%) (46.33%) (17.26%)
Average Days of Receivables
53.77 54.28 50.02 50.84
Free Cash Flow per Share
(0.27) (0.25) (0.23) (0.18)
Free Cash Flow
(211.79) (190.53) (173.96) (133.73)
Capital Expenditures
(14.76) (11.99) (10.66) (10.35)
Other line items
Cash ROIC
(10.33%) (9.63%) (9.20%) (7.30%)
Accounts Receivable Turnover
6.38 5.83 6.61 6.49
Accounts Payable Turnover
7.32 9.09 7.19 6.53
Inventory Turnover
6.68 6.54 5.80 5.43
Average Days of Payables
44.65 37.42 43.34 52.46
Days of Inventory on Hand
57.06 59.92 63.18 64.83
Tax Rate
0.13 (0.07) (0.07) (0.09)
Research and Development Expense of Revenue
18.95% 20.44% 21.06% 21.30%
Selling, General and Administrative Expense of Revenue
37.30% 36.75% 36.57% 35.01%
Share Based Compensation of Revenue
1.69% 1.77% 1.86% 1.85%
Interest Coverage
(1.01) (1.08) (0.97) (1.07)
Operating CF/Net income
1.09 0.79 0.77 1.69
Depreciation/Fixed assets
1.32 1.31 1.31 1.26
Capex/Depreciation
(0.15) (0.12) (0.11) (0.11)
Revenue per Share
0.83 0.81 0.77 0.78
Operating CF per Share
(0.25) (0.24) (0.22) (0.16)
Capex per Share
(0.02) (0.02) (0.01) (0.01)
Capex to Sales
0.02 0.02 0.02 0.02

Fold the line items

Columns are period end dates